Clinical trial

Spectrophon LTD Glucometry Monitor Accuracy

NCT03359629

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Spectrophon Glucometry Monitor Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention YSI 2300 Stat Plus Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Spectrophon LTD Glucometry Monitor Accuracy

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-09-27

PhaseN/A

Conditions

Glucose Metabolism Disordersunresolved

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

Spectrophon Glucometry MonitorDEVICE

YSI 2300 Stat PlusDEVICE

Sponsors & collaborators

Tirat Carmel Mental Health Centerlead sponsor

Ariel Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03359629 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.